Healthcare Sales & Marketing Network News: Ranbaxy Laboratories

Searching News Database: Ranbaxy Laboratories

HSMN NewsFeed - 4 Jan 2017
Titan Pharmaceuticals Appoints Two New Board Members
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 2 May 2016
Endo Announces U.S. District Court Ruling Upholding OPANA(R) ER Intellectual Property
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 24 Sep 2013
Forest Laboratories, Inc. Files Lawsuits against Several Companies for Infringement of Savella(R) Patents
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 17 Aug 2012
Ranbaxy Launches Authorized Generic Of Pioglitazone In The U.S.
Biopharmaceuticals Generics Endocrinology

HSMN NewsFeed - 15 Mar 2010
Ranbaxy Announces Settlement of Actos(R) (Pioglitazone Hydrochloride) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 4 Nov 2008
Sanvar(R) (Debio 8609) for Esophageal Variceal Bleeding - Debiopharm Submits Response to the FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Sep 2008
Ranbaxy Statement on FDA Letters
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Aug 2008
Cipher Pharmaceuticals announces U.S. distribution and supply agreement with Ranbaxy for CIP-ISOTRETINOIN
Biopharmaceuticals Distribution

HSMN NewsFeed - 28 Jul 2008
Ranbaxy Launches Omeprazole 40 mg Capsules
Biopharmaceuticals Generics

HSMN NewsFeed - 17 Jul 2008
Daiichi Sankyo and Ranbaxy Confirm Deal Is Binding and Final, Allay Market Rumour and Speculation
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 Jun 2008
Ranbaxy and Pfizer Settle Lipitor Litigation Worldwide
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 18 Jun 2008
Pfizer and Ranbaxy Settle Lipitor Patent Litigation Worldwide
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 11 Jun 2008
Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
Biopharmaceuticals Generics

HSMN NewsFeed - 30 Apr 2008
U.S. Patent and Trademark Office to Confirm Patentability of Lipitor Basic Patent
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 15 Apr 2008
Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation
Biopharmaceuticals Generics Litigation Distribution

HSMN NewsFeed - 20 Mar 2008
Federal Court of Appeal in Canada Upholds Lipitor Enantiomer Patent, Decision Prevents Launch of Generic Product by Ranbaxy until 2010
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 7 Feb 2008
Ranbaxy Receives Tentative Approval to Manufacture and Market Esomeprazole Magnesium DR Capsules
Biopharmaceuticals FDA Generics

HSMN NewsFeed - 6 Feb 2008
Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
Biopharmaceuticals FDA Generics

HSMN NewsFeed - 25 Jan 2008
Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement
Biopharmaceuticals Litigation

HSMN NewsFeed - 21 Jan 2008
Ranbaxy Announces Settlement of Possible Imitrex(R) Litigation With GlaxoSmithKline
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 20 Nov 2007
Ranbaxy Launches Ran(R)-Tamsulosin Hydrochloride Capsules in Canada
Biopharmaceuticals Generics Regulatory

HSMN NewsFeed - 8 Nov 2007
Ranbaxy and Astellas/Boehringer Ingelheim Enter Into an Agreement to Resolve Tamsulosin U.S. Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 29 Oct 2007
Pfizer to Appeal German Court Decision in Lipitor Patent Case; Company Notes That Ruling Has No Immediate Commercial Impact
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 29 Oct 2007
Ranbaxy Receives Tentative Approval For Valsartan Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 3 Oct 2007
Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
Biopharmaceuticals

HSMN NewsFeed - 2 Oct 2007
Mylan Appoints Rajiv Malik as Executive Vice President, Head of Global Technical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Sep 2007
Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
Biopharmaceuticals Cardiology Generics FDA

HSMN NewsFeed - 30 Aug 2007
Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
Biopharmaceuticals Generics FDA Neurology

HSMN NewsFeed - 20 Aug 2007
Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 26 Jul 2007
Ranbaxy and GlaxoSmithKline Enter Into an Agreement to Settle Valacyclovir U.S. Patent Litigation
Biopharmaceuticals Litigation

HSMN NewsFeed - 10 Jul 2007
Ranbaxy Receives Final Approval To Manufacture and Market Amlodipine Besylate Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 25 Jun 2007
Ranbaxy Launches Pravastatin Sodium 80 Mg Tablets
Biopharmaceuticals Generics

HSMN NewsFeed - 22 Jun 2007
Ranbaxy Receives Tentative Approval for Tamsulosin Capsules
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 20 Jun 2007
Ranbaxy Receives Tentative Approval to Manufacture and Market Amlodipine Besylate Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 29 May 2007
Ranbaxy Successfully Challenges Atorvastatin Patents in Norway
Biopharmaceuticals Litigation Generics

HSMN NewsFeed - 29 May 2007
Pfizer Will Immediately Seek to Appeal Lipitor Patent Ruling in Norway
Biopharmaceuticals Litigation Generics

HSMN NewsFeed - 29 May 2007
Ranbaxy Expands its Presence in the U.S. Dermatology Market Through the Acquisition of 13 Brands from Bristol Myers Squibb
Biopharmaceuticals Dermatology Acquisitions

HSMN NewsFeed - 17 May 2007
Ranbaxy Receives Tentative FDA Approval for Fexofenadine Hydrochloride Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 26 Apr 2007
Ranbaxy Receives Final Approval to Manufacture and Market Zolpidem Tablets for Insomnia
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 25 Apr 2007
Ranbaxy Receives Approval to Manufacture and Market Pravastatin Sodium Tablets in U.S.
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 12 Apr 2007
Ranbaxy Receives FDA Approval To Market Loratadine Antihistamine Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 11 Apr 2007
Ranbaxy Receives Approval To Market Cefprozil Tablets and Cefprozil Powder For Oral Suspension in Canada
Biopharmaceuticals Generics Regulatory

HSMN NewsFeed - 27 Feb 2007
PPD Licenses Statin from Ranbaxy Laboratories
Biopharmaceuticals Licensing

HSMN NewsFeed - 8 Feb 2007
Ranbaxy Gains Final Approval for Sertraline Hydrochloride Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 6 Feb 2007
Ranbaxy Signs a New R&D Agreement With GSK
Biopharmaceuticals

HSMN NewsFeed - 1 Feb 2007
Ranbaxy Receives Final FDA Approval to Manufacture and Market Valacyclovir HCl Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 31 Jan 2007
Ranbaxy Gains FDA Approval to Market Amoxicillin and Clavulanate Potassium for Oral Suspension USP
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 2 Jan 2007
Ranbaxy Granted Final U.S. FDA Approval to Manufacture and Market Atenolol Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 21 Dec 2006
Ranbaxy Granted Final FDA Approval to Market Simvastatin 5, 10, 20 and 40 mg Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 20 Dec 2006
Australian Federal Court Grants Favorable Decision to Ranbaxy on Pfizer's Atorvastatin Patent
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 14 Dec 2006
Ranbaxy Is Granted Final Approval to Manufacture and Market Cefprozil Anti- Infective Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 15 Nov 2006
Ranbaxy Granted Favorable Decision by the U.S. Court of Appeals Regarding Marketing Exclusivity for Simvastatin 80mg
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 2 Nov 2006
Ranbaxy Receives Tentative Approval to Manufacture and Market Cetirizine Hydrochloride Syrup
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 23 Oct 2006
Debiopharm Signs International License Agreements for Sanvar(R)
Biopharmaceuticals Licensing

HSMN NewsFeed - 21 Sep 2006
Ranbaxy Receives Approval to Commercialize Furosemide Tablets in the U.S.
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 13 Sep 2006
Ranbaxy Invalidates Pfizer's 281 Patent in The Netherlands
Biopharmaceuticals Litigation Generics

HSMN NewsFeed - 11 Sep 2006
Ranbaxy Receives FDA Approval to Market Loperamide Hydrochloride and Simethicone Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 18 Jul 2006
Ranbaxy to Acquire the Mundogen Generic Business of GlaxoSmithKline in Spain
Biopharmaceuticals Generics Mergers & Acquisitions

HSMN NewsFeed - 17 Jul 2006
Ranbaxy's Joint Venture in Japan Launches Generic Clarithromycin & Terbinafine Tablets
Biopharmaceuticals Generics

HSMN NewsFeed - 30 Jun 2006
Ranbaxy Receives Approval to Market Cefprozil Suspension
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 23 Jun 2006
Ranbaxy Receives FDA Approval to Market Simvastatin 80mg Tablets with 180-Day Exclusivity
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 2 Jun 2006
Ranbaxy Receives Approval To Market Doxycycline Tablets
Biopharmaceuticals Generics FDA

Return to NewsFeed

Additional items found! 109

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 109 additional stories matching:
Ranbaxy Laboratories
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.